Koutsilieris M - Search Results

1

Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis.

Koutsilieris M, Dimopoulos T, Milathianakis C, Bogdanos J, Karamanolakis D, Pissimissis N, Halapas A, Lembessis P, Papaioannou A, Sourla A. Koutsilieris M, et al. BJU Int. 2007 Jul;100 Suppl 2:60-2. doi: 10.1111/j.1464-410X.2007.06958.x. BJU Int. 2007. PMID: 17594363 Review. No abstract available.

2

Purification and partial sequencing of the major mitogen for human uterine smooth muscle-like cells in leiomyoma extracts.

Sourla A, Koutsilieris M. Sourla A, et al. Among authors: koutsilieris m. J Clin Invest. 1995 Aug;96(2):751-8. doi: 10.1172/JCI118119. J Clin Invest. 1995. PMID: 7635968 Free PMC article.

3

Three-dimensional type I collagen gel system for the study of osteoblastic metastases produced by metastatic prostate cancer.

Koutsilieris M, Sourla A, Pelletier G, Doillon CJ. Koutsilieris M, et al. J Bone Miner Res. 1994 Nov;9(11):1823-32. doi: 10.1002/jbmr.5650091120. J Bone Miner Res. 1994. PMID: 7863832 Free article.

4

Three-dimensional type I collagen gel system containing MG-63 osteoblasts-like cells as a model for studying local bone reaction caused by metastatic cancer cells.

Sourla A, Doillon C, Koutsilieris M. Sourla A, et al. Among authors: koutsilieris m. Anticancer Res. 1996 Sep-Oct;16(5A):2773-80. Anticancer Res. 1996. PMID: 8917385

5

Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.

Koutsilieris M, Reyes-Moreno C, Sourla A, Dimitriadou V, Choki I. Koutsilieris M, et al. Anticancer Res. 1997 May-Jun;17(3A):1461-5. Anticancer Res. 1997. PMID: 9179184 Review.

6

Novel concept of antisurvival factor (ASF) therapy produces an objective clinical response in four patients with hormone-refractory prostate cancer: case report.

Koutsilieris M, Tzanela M, Dimopoulos T. Koutsilieris M, et al. Prostate. 1999 Mar 1;38(4):313-6. doi: 10.1002/(sici)1097-0045(19990301)38:4<313::aid-pros7>3.0.co;2-8. Prostate. 1999. PMID: 10075011

7

Chemotherapy cytotoxicity of human MCF-7 and MDA-MB 231 breast cancer cells is altered by osteoblast-derived growth factors.

Koutsilieris M, Reyes-Moreno C, Choki I, Sourla A, Doillon C, Pavlidis N. Koutsilieris M, et al. Mol Med. 1999 Feb;5(2):86-97. Mol Med. 1999. PMID: 10203574 Free PMC article.

8

Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: development of anti-survival factor therapy for hormone-refractory prostate cancer.

Koutsilieris M, Mitsiades C, Sourla A. Koutsilieris M, et al. Mol Med. 2000 Apr;6(4):251-67. Mol Med. 2000. PMID: 10949907 Free PMC article. Review. No abstract available.

9

Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen.

Koutsilieris M, Lembessis P, Luu-The V, Sourla A. Koutsilieris M, et al. Clin Exp Metastasis. 1999;17(10):823-30. doi: 10.1023/a:1006783330996. Clin Exp Metastasis. 1999. PMID: 11089880

10

Increased insulin-like growth factor 1 activity can rescue KLE endometrial-like cells from apoptosis.

Koutsilieris M, Mastrogamvrakis G, Lembessis P, Sourla A, Miligos S, Michalas S. Koutsilieris M, et al. Mol Med. 2001 Jan;7(1):20-6. Mol Med. 2001. PMID: 11474124 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

359 results

Search Page